GLP-1, Prediabetes, and Metabolic Health

GLP-1 medications like semaglutide and tirzepatide do more than influence weight: by improving how the body responds to its own hormones, they can support blood-sugar control and may benefit people with prediabetes. For many patients, weight loss and metabolic health move together. Whether a GLP-1 program is appropriate is a medical decision determined at consultation, not a retail purchase.

What is prediabetes, and how is it connected to weight?

Prediabetes means blood-sugar levels are higher than normal but not yet in the diabetes range. It is common, often silent, and easy to miss without lab work. Because excess weight and insulin resistance frequently travel together, addressing one may help the other. As a board-certified internist, Dr. Marcelo Taborga, MD, looks at the whole metabolic picture rather than weight in isolation, which is exactly the kind of context prediabetes calls for. He reviews blood pressure, lipids, blood sugar, your medications, and your history before recommending anything, so the plan fits the person rather than a label.

How can GLP-1 medications affect metabolic health?

GLP-1 medications work in part by influencing appetite and slowing stomach emptying, which supports a gradual calorie deficit. They also affect how the body handles glucose. Brand names you may recognize are useful factual reference points: Ozempic and Mounjaro are FDA-approved for type 2 diabetes, while Wegovy and Zepbound are approved for chronic weight management. A physician determines which situation, if any, applies to you. Potential benefits a physician may discuss include:

- Improved blood-sugar regulation in appropriate patients - Reduced appetite and gradual, sustained weight loss over months - Better metabolic markers when paired with nutrition and activity - Closer monitoring of related conditions such as blood pressure and lipids

Why does an internist's whole-health view matter?

Weight is one signal among many, and treating it in a vacuum misses the point. GLP-1 medications are prescription treatments that are not appropriate for everyone, and contraindications must be assessed individually. An internist is trained to see how metabolic factors interact, to recognize when lab work is needed, and to manage common effects such as nausea or other GI upset, which may occur and should be discussed with your physician. This is care designed around your full health, not a single number on a scale, and it is not a substitute for ongoing medical attention.

What supports lasting metabolic improvement?

Medication is one tool. Lasting change also depends on adequate protein to preserve muscle, balanced nutrition, sleep, and regular movement. Throughout New York City, demanding schedules can make consistency hard, which is exactly why physician-supervised care and realistic, individualized planning matter. The goal is durable improvement you can maintain, and results vary from person to person.

Where is this care available?

Captivate Medical Wellness practices in the Flatiron District of Manhattan, in New York County, convenient to Union Square, NoMad, and Gramercy Park, and close to the 23rd Street and Union Square subway stations. Care is offered in English and Spanish, with a calm, conservative approach grounded in your individual health rather than trends.

Ready to look at your full metabolic picture?

If you are concerned about prediabetes or want a physician-led view of your metabolic health, schedule a consultation with Captivate Medical Wellness in the Flatiron District by calling (332) 237-3661. Dr. Taborga will determine whether a physician-supervised GLP-1 program is appropriate for you.